PALB2 Associated With Breast, Ovarian, Pancreatic Cancer Risks

Cancer Therapy Advisor (1/7, Bennett) reports in a trial of 524 families across 21 countries, “germline PALB2 pathogenic variants were associated with an increased risk for female breast cancer, male breast cancer, ovarian cancer, and pancreatic cancer, a...